Abstract
A 57-year-old woman suffering from limb-girdle muscular dystrophy type 2I (LGMD, fukutin-related protein gene mutation) took part in body-weight supported treadmill therapy with the voluntary driven exoskeleton HAL®. First clinical signs were evident 11 years ago. The diagnosis has been determined genetically in 2009. Clinical examination showed floppy quadriparesis with typical proximal pronouncement (MRC 3-4/5), positive Trendelenburg sign bilateral and lumbar hyperlordosis. Due to the muscular dystrophy, the patient is retired. She needs a wheeled walker to deal with longer distances, e. g shopping. Her muscle weakness causes falls regularly. The patient gave written informed consent to participate in a clinical application observation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Musculoskeletal Disorders and Treatment
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
